Cardiovascular Risk Reduction with Icosapent Ethyl
- PMID: 31018076
- DOI: 10.1056/NEJMc1902165
Cardiovascular Risk Reduction with Icosapent Ethyl
Comment in
-
Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.N Engl J Med. 2019 Apr 25;380(17):1678. doi: 10.1056/NEJMc1902165. N Engl J Med. 2019. PMID: 31018077 No abstract available.
Comment on
-
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.
-
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.N Engl J Med. 2019 Jan 3;380(1):33-44. doi: 10.1056/NEJMoa1809944. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415629 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical